Printer Friendly

MS: cooling it chemically.

People with multiple sclerosis tend to suffer fewer symptoms of the nerve-degenerating disease in cold weather. Patients who can walk often lose that ability when they have a fewer. To exploit this temperature dependence, Floyd Davis and colleagues at Rush Medical College in Chicago have been working with 4-aminopyridine, a chemical that mimics the effect of cold on nerves. The drug looks promising but much more work needs to be done before it can be considered for use, Davis says.

Cold slows down thee nerve impulse, which is electrically conducted, resulting in an increased current. That can power the impulse through the degenerated part of the nerve, Davis says. The drug slows down the nerve impulse by blocking the flow of potassium ions, which conduct the current.

In a study of 12 patients with particularly heat-sensitive MS, being presented this month in Chicago at the American Neurological Association meeting, Davis and his colleagues found that seven of the 12 had a significant improvement in vision, and five showed a greater use of their arms and legs. At the moment, 4-aminopyridine has to be administered intravenously, and its effects wear off within a few hours.

"It offers hope for a way of treating the disease, but it won't reverse the process," Davis notes.

Byron Waksman, director of research for the National Multiple Sclerosis Society, which funded the work, says, "It's not anything that can be used as a treatment, but it shows the approach has merit."
COPYRIGHT 1985 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1985, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:multiple sclerosis treated with 4-aminopyridine
Publication:Science News
Date:Oct 5, 1985
Words:245
Previous Article:Uncharted outpatient illnesses.
Next Article:Predicting childhood diabetes.
Topics:


Related Articles
Oxygen and multiple sclerosis.
Multiple sclerosis: strategies for rehabilitation counselors.
Plasma exchange for unrelenting MS attacks.
International MS Week in Basel, Switzerland.
A NEW VIEW of Progressive MS.
Novantrone approved to treat MS progression.
Botox for MS symptoms? (news).
Medical, pyschological, social, and programmatic barriers to employment for people with multiple sclerosis.
FDA CLEARS BIOMS MEDICAL FOR PHASE III MULTIPLE SCLEROSIS.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters